L. M. Kaiser

发表

Long-term, high-level hepatic secretion of acid α-glucosidase for Pompe disease achieved in non-human primates using helper-dependent adenovirus

A. Amalfitano, D. Palmer, P. Ng, 2016, Gene Therapy.

Biomarkers for classification and class prediction of stress in a murine model of chronic subordination stress

C. Buske, D. Langgartner, S. Reber, 2018, PloS one.

CXCR4 in Waldenström’s Macroglobulinema: chances and challenges

C. Buske, S. Treon, Z. Hunter, 2020, Leukemia.

Interleukin-10 does not contribute to the anti-contractile nature of PVAT in health.

S. Watts, R. K. Kumar, C. Rockwell, 2021, Vascular pharmacology.

Acute myeloid leukemia cells are targeted by the naturally occurring CXCR4 antagonist EPI-X4

C. Buske, J. Münch, E. Hildt, 2022, bioRxiv.

A phase II study of the PI3K inhibitor copanlisib in combination with the anti-CD20 monoclonal antibody rituximab for patients with marginal zone lymphoma: treatment rationale and protocol design of the COUP-1 trial

C. Buske, J. Dreyhaupt, T. Barth, 2021, BMC Cancer.

Phase II trial evaluating the efficacy and safety of the anti-CD20 monoclonal antibody obinutuzumab in patients with marginal zone lymphoma.

C. Buske, J. Dreyhaupt, T. Barth, 2020, Future oncology.

Controlled stem cell amplification by HOXB4 depends on its unique proline-rich region near the N terminus.

Carsten Müller-Tidow, Christian Buske, Wolfgang Hiddemann, 2017, Blood.

Targeting of CXCR4 by the Naturally Occurring CXCR4 Antagonist EPI-X4 in Waldenström’s Macroglobulinemia

C. Buske, J. Münch, E. Hildt, 2020, bioRxiv.